On Friday, December 5, the U.S. Meals and Drug Administration (FDA) cautioned customers to not use counterfeit Ozempic (semaglutide) discovered within the U.S. drug provide chain. The FDA introduced it had not too long ago seized dozens of counterfeit 1 mg injection models distributed illegally exterior Novo Nordisk’s licensed provide chain. The seized counterfeit merchandise had been within the official U.S. drug provide chain.
The FDA advises sufferers, wholesalers, retail pharmacies, and healthcare professionals to test the Ozempic merchandise they’ve acquired and never use, distribute, or promote merchandise that include the counterfeit data above. Opposed occasions or negative effects needs to be reported to the FDA’s MedWatch Security Info and Opposed Occasion Reporting Program.
Novo Nordisk said in a press launch that additional analyses might be carried out, together with intensive visible examination and deliberate chemical testing of the seized product.
Counterfeit merchandise are labeled with the lot quantity PAR1229, which can also be used on genuine merchandise. You’ll be able to determine the counterfeit by the location of the EXP/LOT textual content on the pen’s label. The counterfeit has the EXP/LOT textual content on the left aspect of the expiration date and lot quantity, whereas the genuine Ozempic pen has it positioned above the expiration date and lot quantity.
